[Controlled clinical study of the clinical efficacy and tolerability of a new nonsteroidal anti-inflammatory preparation, imidazole-2-hydroxybenzoate, in patients with pain and phlogistic syndromes of varying etiopathogenesis].
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007093:Imidazoles; D012459:Salicylates; C043292:imidazole-2-hydroxybenzoate
Studio clinico controllato sull'efficacia e sulla tollerabilità clinica di un nuovo preparato antinfiammatorio non steroideo, l'imidazolo 2-idrossibenzoato, in pazienti con sindromi algiche e flogistiche a varia eziopatogenesi.